Statin use and incident cardiovascular events in renal transplant recipients.
Josephine L C AndersonMarkus van der GietAntonio W Gomes NetoStephan J L BakkerUwe J F TietgePublished in: European journal of clinical investigation (2021)
In conclusion, statin use does not significantly decrease incident CV events in an overall RTR cohort, but is independently associated with CV-specific mortality and events in cyclosporine using RTR, possibly due to a bilateral pharmacological interaction.